GRDN today
$49.52+$0.14 (+0.28%)close Nov 13, 2026Trend
DailyUptrend (starting)
4 hourLeaning Bullish
1 hourStrong Bullish
15 minSymmetric Triangle
5 minDescending Triangle
Daily trend turns down below $35.90
Key levels
Support$48.33
Support$42.26
Latest news & SEC filings
EarningsGuardian Pharmacy Services posts Q3 2026 results, lifts full-year guidance
EarningsGuardian Pharmacy Service holds Q3 2026 earnings call
GuidanceGuardian Pharmacy Service lifts FY2026 sales outlook to $1.440B-$1.460B
SEC FilingGuardian Pharmacy Services, Inc. filed a report on a major company event (Form 8-K)
EarningsGuardian Pharmacy Service tops quarterly profit and revenue estimates
All GRDN news →About Guardian Pharmacy
Guardian Pharmacy supplies prescription medications and related pharmacy services to long-term care communities, with a focus on assisted living residences and behavioral care settings such as group homes. It dispenses drugs in compliance packaging, offers clinical consulting and caregiver training, and provides data analytics tools to facilities. Its customers include residents, care facilities, and health plan payors, served through pharmacies across the United States.
Based on the company's 10-K filed Mar 11, 2026.
NYSE · Healthcare
Guardian Pharmacy Services, Inc. (GRDN)
What Is the Price Target for GRDN?
SEPT Low Target
$44.00
SEPT Mid Target
$48.00
SEPT High Target
$52.00
Analyst Consensus
$48.00
Is GRDN a Buy or Sell Right Now?
Thesis
- •Revenue growing 17.9% YoY with UNKNOWN trend — consistent growth.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for GRDN.
Start Free Trial →Is GRDN Overvalued or Undervalued?
Valuation Verdict
OVERVALUED
Methods Used
P/E Forward, Analyst Consensus
Fair Value
$42.01
36
Moat Score
NONE
7/9
Piotroski Score
N/A
Altman Z-Score
What Is Smart Money Doing with GRDN?
Insider Signal
NEUTRAL
0 buys / 3 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Cardinal Equity Fund, L.P. | other | Buy | 471,057 | - | Sep 27, 2026 |
| Forbes Kendall | other | Buy | 608,570 | - | Sep 27, 2026 |
| BINDLEY WILLIAM E | director 10% owner | Buy | 6,100,175 | - | Sep 27, 2026 |
| Mudd William Franklin | officer | Buy | 38,282 | - | Sep 27, 2026 |
| Weir Robert | officer | Buy | 23,450 | - | Sep 27, 2026 |
| Ackerman John | director | Buy | 1,413,939 | - | Sep 27, 2026 |
| Ackerman John | director | Buy | 471,057 | - | Sep 27, 2026 |
| Salentine Thomas J Jr | director 10% owner | Buy | 6,100,175 | - | Sep 27, 2026 |
| Martin David Norman | officer | Buy | 39,865 | - | Sep 27, 2026 |
| Pharmacy Investors, LLC | other | Buy | 1,413,939 | - | Sep 27, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →GRDN Growth Story
Revenue YoY
17.9%
3yr Revenue CAGR
N/A%
EPS Growth YoY
N/A
FCF Growth YoY
100.8%
Revenue Trend
UNKNOWN
Dark Pool Trades for GRDN
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for GRDN, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 21:00:53 | $49.52 | 1,494 | $$74K | SELL |
| 21:00:20 | $49.52 | 1,409 | $$70K | SELL |
| 20:24:56 | $49.41 | 1,100 | $$54K | SELL |
| 20:02:00 | $49.23 | 1,100 | $$54K | MIDPOINT |
| 19:35:39 | $49.54 | 1,514 | $$75K | BUY |
5 dark pool trades shown · $$327K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Guardian Pharmacy Services, Inc. (GRDN) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →GRDN — frequently asked questions
What is GRDN stock price today?
Guardian Pharmacy Services, Inc. (GRDN) is at $49.52, up 0.28% (+$0.14) at the Nov 13, 2026 close.
Why is GRDN stock moving today?
Latest GRDN news — Nov 5, 2026: Guardian Pharmacy Services posts Q3 2026 results, lifts full-year guidance · Nov 5, 2026: Guardian Pharmacy Service holds Q3 2026 earnings call
What is the GRDN price target?
The average analyst price target for GRDN is $48.00, ranging from $44 to $52, based on 6 analysts. Latest: Keybanc initiates on Sep 23, 2026.
What do analysts rate GRDN?
Analyst ratings for GRDN: 0 Buy, 7 Hold, 0 Sell — consensus Hold.
Did GRDN beat earnings?
GRDN last reported on Aug 6, 2026: EPS $0.29 vs $0.26 expected — a beat of 10.8%.
Does GRDN pay a dividend?
GRDN does not currently pay a dividend.
What are GRDN support and resistance levels?
Support: $48.33, $42.26, $39.71.
What are insiders doing with GRDN?
Insider activity: NEUTRAL, 0 buys and 3 sells in the last 90 days.
What is the latest news on GRDN?
Nov 5, 2026: Guardian Pharmacy Services posts Q3 2026 results, lifts full-year guidance · Nov 5, 2026: Guardian Pharmacy Service holds Q3 2026 earnings call · Nov 5, 2026: Guardian Pharmacy Service lifts FY2026 sales outlook to $1.440B-$1.460B